» Articles » PMID: 21342215

Review: The Neurobiology of Varicella Zoster Virus Infection

Overview
Specialty Neurology
Date 2011 Feb 24
PMID 21342215
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Varicella zoster virus (VZV) is a neurotropic herpesvirus that infects nearly all humans. Primary infection usually causes chickenpox (varicella), after which virus becomes latent in cranial nerve ganglia, dorsal root ganglia and autonomic ganglia along the entire neuraxis. Although VZV cannot be isolated from human ganglia, nucleic acid hybridization and, later, polymerase chain reaction proved that VZV is latent in ganglia. Declining VZV-specific host immunity decades after primary infection allows virus to reactivate spontaneously, resulting in shingles (zoster) characterized by pain and rash restricted to one to three dermatomes. Multiple other serious neurological and ocular disorders also result from VZV reactivation. This review summarizes the current state of knowledge of the clinical and pathological complications of neurological and ocular disease produced by VZV reactivation, molecular aspects of VZV latency, VZV virology and VZV-specific immunity, the role of apoptosis in VZV-induced cell death and the development of an animal model provided by simian varicella virus infection of monkeys.

Citing Articles

Herpes zoster ophthalmicus following recombinant zoster vaccine: A case report and brief literature review.

Garcia J, Haddadin R IDCases. 2024; 37:e02070.

PMID: 39296531 PMC: 11407963. DOI: 10.1016/j.idcr.2024.e02070.


Exploring viral neuropathic pain: Molecular mechanisms and therapeutic implications.

Xu S, Li H, Ai Z, Guo R, Cheng H, Wang Y PLoS Pathog. 2024; 20(8):e1012397.

PMID: 39116040 PMC: 11309435. DOI: 10.1371/journal.ppat.1012397.


Associations of infections and vaccines with Alzheimer's disease point to a role of compromised immunity rather than specific pathogen in AD.

Ukraintseva S, Yashkin A, Akushevich I, Arbeev K, Duan H, Gorbunova G Exp Gerontol. 2024; 190:112411.

PMID: 38548241 PMC: 11060001. DOI: 10.1016/j.exger.2024.112411.


The emerging mechanism behind viral infections and extracellular vesicles hypotheses leading to neuroinflammation and Alzheimer's disease pathology.

Anwar M Ibrain. 2023; 9(1):63-71.

PMID: 37786515 PMC: 10529198. DOI: 10.1002/ibra.12090.


Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir.

Bakacs T, Sandig V, Kovesdi I Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259374 PMC: 9958712. DOI: 10.3390/ph16020226.


References
1.
Hayward A, Zerbe G, Levin M . Clinical application of responder cell frequency estimates with four years of follow up. J Immunol Methods. 1994; 170(1):27-36. DOI: 10.1016/0022-1759(94)90242-9. View

2.
Gilden D, Beinlich B, Rubinstien E, Stommel E, Swenson R, Rubinstein D . Varicella-zoster virus myelitis: an expanding spectrum. Neurology. 1994; 44(10):1818-23. DOI: 10.1212/wnl.44.10.1818. View

3.
Lewis J, Nagae Y, Tano Y . Progressive outer retinal necrosis after bone marrow transplantation. Am J Ophthalmol. 1996; 122(6):892-5. DOI: 10.1016/s0002-9394(14)70391-5. View

4.
Gershon A, Steinberg S . Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections. Infect Immun. 1979; 25(1):170-4. PMC: 414434. DOI: 10.1128/iai.25.1.170-174.1979. View

5.
Anderson J, KEAL E . Cervical herpes zoster and diaphragmatic paralysis. Br J Dis Chest. 1969; 63(4):222-6. DOI: 10.1016/s0007-0971(69)80022-7. View